Comparison of the anti-inflammatory effects of esomeprazole and fexuprazan in lipopolysaccharide-stimulated RAW 264.7 macrophages. (PubMed, BMC Pharmacol Toxicol) - May 10, 2026 - "These results suggest that FEXU has a superior anti-inflammatory effect relative to that of ESO, indicating its potential as an anti-inflammatory agent."
Journal • Inflammation • MAPK8 • MRC1
|
|
Daye Lee; Gi-Beom Ju; Min Jai Cho; Min Je Kim; Seil Sohn; Seong Jun Kim; Wan-Kyu Ko
|